Business Life Insurance Weekly Industry News Wrap

Each week, Business Life Insurance Australia delivers a clear, trustworthy wrap of the stories shaping risk and resilience for Australian businesses. In under 15 minutes, get concise updates on key person risk, succession and governance shifts, tax and compliance headlines, regulator and court developments, and market trends impacting SMEs and executives. Expect plain-English context, what it means for your organisation, and the signals to watch ahead—so you can plan with confidence.

This Week:

This week: Australia edges closer to banning genetic test results in life insurance underwriting; the Federal Court approves a $140m settlement over alleged group life overcharging in super; AFCA rules that “level” premiums can be repriced under policy terms, reinforcing the need to budget for movements; and adviser capacity lifts while the FAAA surveys members on CSLR levy impacts. Takeaways for SMEs: review super group cover alongside key person and buy‑sell arrangements, stress‑test premium paths, and coordinate application timing and medical tests. For tailored help and quotes, visit business-life-insurance.com.au.

EPISODE 1509 | Business Life Insurance Weekly Industry News Wrap | Tue, 31st Mar 2026

31 Mar 2026 | Paige Estritori

00:00:00

00:00:00

1x

Read Full Transcript:

Hello and welcome to Business Life Insurance Weekly Industry News Wrap; Im Paige Estritori, and its Tuesday, 31 March 2026. First, a major reform is close: Australia is moving to ban the use of genetic test results in life insurance underwriting after legislation passed the House and moved to the Senate. If it becomes law, owners and key staff could proceed with medically‑advised testing without worrying it will affect future cover terms. If youre planning new cover or increases, talk timing with your adviser so your application and any tests line up sensibly. Next, the Federal Court has approved a $140 million settlement in a class action over alleged overcharging of group life premiums in super. For employers, expect trustees and insurers to keep reviewing pricing and disclosures. Its a good cue to check the value and design of the default life, TPD and income protection inside your staff super—and make sure it complements any key person or buy‑sell arrangements you rely on for continuity. Meanwhile, a fresh decision from the Australian Financial Complaints Authority, or AFCA, confirms so‑called “level” premiums arent fixed for life if the policy terms allow repricing. AFCA couldnt rule on the fairness of the amount, but did award minor compensation for admin errors. The practical step: build headroom into budgets and ask your broker for stress‑tested premium paths and options to keep essential protection in place if rates move. Finally, adviser capacity looks to be improving, with industry data showing adviser numbers hitting a new high for 2026 last week, while the Financial Advice Associations survey on the Compensation Scheme of Last Resort, or CSLR, is gathering evidence on levy impacts. More advisers should mean faster access to guidance for structuring key person and succession cover; just expect continued transparency around fee components as funding settings evolve. Thats the wrap. For clear guidance and to compare business life insurance—including key person and buy‑sell cover—visit business-life-insurance.com.au and get your free assessment. Im Paige Estritori; thanks for listening, and Ill see you next week.

The information on this website is general in nature and does not take into account your objectives, financial situation, or needs. Consider seeking personal advice from a licensed adviser before acting on any information.